Gil Blum
Stock Analyst at Needham
(2.05)
# 2,817
Out of 4,870 analysts
389
Total ratings
34.77%
Success rate
-5.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Maintains: Buy | $125 → $50 | $18.87 | +164.97% | 32 | Jun 16, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $2.21 | +352.49% | 28 | Jun 12, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $81 | $45.55 | +77.83% | 22 | May 20, 2025 | |
| CELC Celcuity | Reiterates: Buy | $29 | $11.47 | +152.83% | 16 | May 15, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $23 → $18 | $1.62 | +1,011.11% | 6 | May 15, 2025 | |
| ABSI Absci | Reiterates: Buy | $9 | $2.76 | +226.09% | 4 | May 14, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $63.64 | +64.99% | 23 | Dec 10, 2024 | |
| FATE Fate Therapeutics | Reiterates: Hold | n/a | $1.14 | - | 8 | Jun 12, 2025 | |
| TSHA Taysha Gene Therapies | Reiterates: Buy | $8 | $2.49 | +221.29% | 28 | Jun 10, 2025 | |
| RCKT Rocket Pharmaceuticals | Downgrades: Hold | $42 | $2.63 | +1,496.96% | 21 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.75 | +473.07% | 17 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.74 | +155.47% | 18 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $9.83 | +306.92% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.36 | +2,122.84% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $8 | $4.83 | +65.63% | 23 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $11.98 | +125.38% | 24 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $31.12 | +128.15% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.45 | +520.69% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $2.46 | +62.60% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.01 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.42 | +252.11% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $5.71 | - | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.47 | +751.06% | 9 | Aug 2, 2024 |
Sarepta Therapeutics
Jun 16, 2025
Maintains: Buy
Price Target: $125 → $50
Current: $18.87
Upside: +164.97%
Autolus Therapeutics
Jun 12, 2025
Reiterates: Buy
Price Target: $10
Current: $2.21
Upside: +352.49%
CRISPR Therapeutics AG
May 20, 2025
Reiterates: Buy
Price Target: $81
Current: $45.55
Upside: +77.83%
Celcuity
May 15, 2025
Reiterates: Buy
Price Target: $29
Current: $11.47
Upside: +152.83%
Artiva Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $1.62
Upside: +1,011.11%
Absci
May 14, 2025
Reiterates: Buy
Price Target: $9
Current: $2.76
Upside: +226.09%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $63.64
Upside: +64.99%
Fate Therapeutics
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.14
Upside: -
Taysha Gene Therapies
Jun 10, 2025
Reiterates: Buy
Price Target: $8
Current: $2.49
Upside: +221.29%
Rocket Pharmaceuticals
May 27, 2025
Downgrades: Hold
Price Target: $42
Current: $2.63
Upside: +1,496.96%
May 15, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.75
Upside: +473.07%
May 13, 2025
Reiterates: Buy
Price Target: $7
Current: $2.74
Upside: +155.47%
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $9.83
Upside: +306.92%
May 8, 2025
Reiterates: Buy
Price Target: $8
Current: $0.36
Upside: +2,122.84%
May 6, 2025
Maintains: Buy
Price Target: $11 → $8
Current: $4.83
Upside: +65.63%
Apr 29, 2025
Reiterates: Buy
Price Target: $27
Current: $11.98
Upside: +125.38%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $31.12
Upside: +128.15%
Apr 8, 2025
Reiterates: Buy
Price Target: $9
Current: $1.45
Upside: +520.69%
Apr 4, 2025
Reiterates: Buy
Price Target: $4
Current: $2.46
Upside: +62.60%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.01
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.42
Upside: +252.11%
Feb 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.71
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $4
Current: $0.47
Upside: +751.06%